Phase I/II trial of AMZ 0026 patients seropositive for HIV-1.

Trial Profile

Phase I/II trial of AMZ 0026 patients seropositive for HIV-1.

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 20 Mar 2012

At a glance

  • Drugs AMZ 0026 (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 20 Mar 2012 Planned number of patients changed to 32.
    • 20 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top